跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 160 条关于
“ErbB2”
全部
160
临床试验
105
药物
15
机构
0
资讯
40
2年前
One-Year Trastuzumab Improves Disease-Free Survival in ERBB2-Positive Breast Cancer
去年
HER2 Amplification Varies Significantly Across Cancers and Patient Subgroups, Study Finds
去年
High TIL Levels Could Enable Shorter Trastuzumab Treatment in Early ERBB2-Positive Breast Cancer
去年
Dendritic Cell Immunotherapy Shows Promise in Early-Stage ERBB2-Positive Breast Cancer
4年前
Margetuximab Not Cost-Effective Compared to Trastuzumab for ERBB2-Positive Advanced Breast Cancer
2年前
HER2DX® Genomic Test Demonstrates Predictive Value in Advanced HER2+ Breast Cancer
去年
Genomic Profiling of HER2-Low Metastatic Breast Cancer Reveals Potential Therapeutic Strategies
9个月前
HER2 Amplification Linked to Worse Outcomes in First-Line Metastatic Colorectal Cancer Treatment
去年
Targeted Therapies Transform Biliary Tract Cancer Treatment Landscape with FGFR2 Inhibitors Leading Clinical Advances
去年
BostonGene Advances Precision Oncology with AI-Driven Molecular Profiling Research at Major Cancer Symposiums
第 1 页,共 4 页
上一页
下一页